ReportsandIntelligence: Global Orphan Drugs Market 2014-2018

1
Global Orphan Drugs Market 2014-2018
Published on Jan 2014 No. of Pages 66
Reports and Intelligence
2
Description
TechNavio's analysts forecast the Global Orphan
Drugs market to grow at a CAGR of 5.67 percent
over the period 2013-2018. One of the key factors
contributing to this market growth is the shorter
development timelines. The Global Orphan Drugs
market has also been witnessing the growing
awareness of orphan drugs. However, the high cost
of drug development could pose a challenge to the
growth of this market. TechNavio's report, the
Global Orphan Drugs Market 2014-2018, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, and the EMEA and APAC
regions it also covers the Global Orphan Drugs
market landscape and its growth prospects in the
coming years. The report also includes a
discussion of the key vendors operating in this
market.Key vendors dominating this space are
Novartis AG, F. Hoffmann-La Roche Ltd., Celgene
Corp., Pfizer Inc., and Sanofi S.A.Other vendors
mentioned in the report are Actelion
Pharmaceuticals Ltd., Alexion Pharmaceuticals
Inc., Amgen Inc., Baxter International Inc.,
Biogen Idec Inc., Bristol-Myers-Squibb Co.,
GlaxoSmithKline plc, Eli Lilly Co., Merck KGaA,
Novo Nordisk A/S, Onyx Pharmaceuticals Inc.,
Shire plc, and Vertex Pharmaceuticals Inc.
3
Table Of Content

• Executive Summary
• List of Abbreviations
• Scope of the Report
• Market Research Methodology
• Market Landscape
• Market Segmentation by Product Type
• Geographical Segmentation
• Get full TOC at http//www.reportsandintelligence
  .com/global-insulin-pumps-2014-2018-market/table-o
  f-contents

4
Questions answered in this report

• What will the market size be in 2018 and what
  will the growth rate be?
• What are key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats
  faced by key vendors?
• What are the strengths and weaknesses of each of
  these key vendors?
• Get detailed information at http//www.reportsand
  intelligence.com/global-orphan-drugs-2014-2018-mar
  ket

5
Get access to detailed information at
http//www.reportsandintelligence.com/global-orpha
n-drugs-2014-2018-market Request for Discount
at http//www.reportsandintelligence.com/purchas
e-enquiry/17553